News and Trends 29 Aug 2018 Affimed Collaborates with Genentech in Cancer Immunotherapy Deal Worth €4.4B The German biotech will partner with Genentech, part of the Roche Group, to develop targeted cancer therapies that engage both innate and adaptive immune cells. Affimed will receive €82M ($96M) upfront from the US giant to develop its immunotherapy ROCK (Redirected Optimized Cell Killing) platform, which uses both natural killer cells and T-cells to target […] August 29, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 24 Aug 2018 Shire gets US market approval for rare inflammatory disease drug The UK-US biotech giant’s drug Takhzyro has been approved by the FDA to prevent attacks of hereditary angioedema, a rare genetic disease that causes swelling around the body. Hereditary angioedema is a potentially life threatening genetic condition that people can inherit from either of their parents. Takhzyro (lanadelumab-flyo) is a first-in-class monoclonal antibody drug that […] August 24, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 22 Aug 2018 Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test A blood test developed by Swedish-biotech Immunovia and scientists from Linköping University accurately diagnoses patients with rheumatoid arthritis even if they test negative for two common biomarkers. The current gold standard test for rheumatoid arthritis, which affects 5-7 million people in the US and Europe, misses a substantial number of people who have the condition. […] August 22, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 22 Aug 2018 Producing Cost-Effective and Eco-Friendly Biofuel With Seawater UK researchers have developed a technique for making bioethanol from seawater, which they hope will make production of the biofuel cheaper and more environmentally friendly than current methods. At present, bioethanol production uses very large amounts of freshwater – 1000-10,000 liters water per 1 liter bioethanol. They also require large amounts of plant biomass to […] August 22, 2018 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Aug 2018 Here are our 10 favorite biotech books you should read this summer Here is a list of our 10 best biotech books for you, ranging from new and classic popular science to science fiction, as selected by the team at Labiotech. The summer is sadly coming to a close very soon, but we wanted to provide you with a bit more Labiotech entertainment for its last few weeks. I […] August 20, 2018 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 26 Jul 2018 Plastic Type Key to Eco-Friendly Breakdown by Soil Microbes Swiss research shows that bacteria and fungi in the soil are able to comprehensively break down some types of plastic, but not others. Thin plastic ‘mulch’ films are commonly used by farmers on fields to prevent weeds, but it is often extremely difficult to collect these films after they have been used. “While plastic that […] July 26, 2018 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 28 Jun 2018 The Race to Get CRISPR to the Clinic: Hope Versus Hype In 2016, German pharma giant Bayer took a bold step and decided to partner with CRISPR Therapeutics to form a company that could join the race to be first into the clinic with a CRISPR therapy. Peter Nell worked at Bayer for many years and was one of the founding team of Casebia Therapeutics. Now […] June 28, 2018 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jun 2018 Radiotherapy-Enhancing Cancer Nanomedicine Secures Good Phase II/III Results A nanomedicine designed to help amplify and focus radiation treatment on hard to treat soft tissue sarcoma cells has achieved positive Phase II/III trial results for French-American biotech Nanobiotix. “Data are exceptional and show without any doubt an improvement of radiation therapy impact,” commented Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at […] June 22, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jun 2018 Spider Silk Shows Promise in Vaccine Field Swiss and German scientists have engineered spider-silk microparticles that can be used to protect a vaccine particle, allow it to enter immune cells and trigger T-cell immunity without toxic effects. The team, partnered by AMSilk — the German biotech behind Adidas’ biodegradable shoes, hopes their technique will allow more targeted and stable vaccines against difficult targets […] June 12, 2018 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2018 Best of European Biotech at ASCO 2018 Not able to attend the biggest cancer conference of the year? No problem. We have summarized what we think are the most interesting therapy developments presented by European biotech’s at ASCO this year. Once again, the cream of the cancer specialist crop gathered in Chicago to discuss and present the latest findings in cancer research at […] June 6, 2018 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 30 May 2018 How to Close a €3.9B Acquisition Deal for Your Biotech Company Ablynx, one of the big giants in the European biotech arena, closed the final stages of its €3.9B acquisition deal with Sanofi earlier this month, after details were announced in January. Edwin Moses, CEO of Ablynx, shared the company’s success story with attendees at our recent Refresh Meetup in Brussels. The technology behind Ablynx’s success […] May 30, 2018 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 29 May 2018 Positive House Dust Mite Immunotherapy Results for UK Biotech British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s been a good month for Allergy Therapeutics, which also reported positive Phase II results for its grass pollen allergy vaccine trial last week. It seems to be doing well, with a number of products targeting common allergies in late stage […] May 29, 2018 - 1 minutemin - By Helen Albert Share WhatsApp Twitter Linkedin Email